These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8856259)

  • 21. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
    Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D
    J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of lipid and fatty acid metabolism between minimal change nephrotic syndrome and membranous nephropathy.
    Fujita T; Nakamura N; Kumasaka R; Shimada M; Murakami R; Osawa H; Yamabe H; Okumura K
    In Vivo; 2006; 20(6B):891-3. PubMed ID: 17203785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compositional lipoprotein changes and low-density lipoprotein susceptibility to oxidation in chronic renal failure patients with heavy proteinuria.
    Karabina SA; Pappas H; Miltiadous G; Bairaktari E; Christides D; Tselepis A; Elisaf M; Siamopoulos K
    Nephron Clin Pract; 2003; 95(3):c77-83. PubMed ID: 14646367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of lipids, lipoproteins, and apolipoproteins in Menkes' disease.
    Blackett PR; Lee DM; Donaldson DL; Fesmire JD; Chan WY; Holcombe JH; Rennert OM
    Pediatr Res; 1984 Sep; 18(9):864-70. PubMed ID: 6483510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma kinetics of an LDL-like non-protein nanoemulsion and transfer of lipids to high-density lipoprotein (HDL) in patients with rheumatoid arthritis.
    Pozzi FS; Maranhão RC; Guedes LK; Borba EF; Laurindo IM; Bonfa E; Vinagre CG
    J Clin Lipidol; 2015; 9(1):72-80. PubMed ID: 25670363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
    Vuong TD; Stroes ES; Willekes-Koolschijn N; Rabelink TJ; Koomans HA; Joles JA
    Kidney Int; 1999 Mar; 55(3):1005-10. PubMed ID: 10027937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
    Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
    Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome.
    Zilleruelo G; Hsia SL; Freundlich M; Gorman HM; Strauss J
    J Pediatr; 1984 Jan; 104(1):61-4. PubMed ID: 6690676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein metabolism in postmenopausal and oophorectomized women.
    Wakatsuki A; Sagara Y
    Obstet Gynecol; 1995 Apr; 85(4):523-8. PubMed ID: 7898827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum lipoproteins, apolipoproteins and intravenous fat tolerance in young athletes.
    Ericsson M; Johnson O; Tollin C; Furberg B; Backman C; Angquist K
    Scand J Rehabil Med; 1982; 14(4):209-12. PubMed ID: 7178868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of the clinical significance of lipoprotein (a) in nephrotic syndrome.
    Takegoshi T; Kitoh C; Haba T; Hirai J; Wakasugi T; Saga T; Yamazaki Y; Mabuchi H
    Jpn J Med; 1991; 30(1):21-5. PubMed ID: 1830908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.
    Forte TM; Nichols AV; Krauss RM; Norum RA
    J Clin Invest; 1984 Nov; 74(5):1601-13. PubMed ID: 6501564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of castration and testosterone administration on serum lipoproteins and their apoproteins in male spontaneously hypertensive rat.
    Takeuchi N; Go S; Murase M; Nomura Y; Takase H; Uchida K
    Endocrinology; 1986 May; 118(5):1787-94. PubMed ID: 3084207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-released plasma lipase activities, lipoprotein and apoprotein levels in young adult cyclists and sedentary men.
    Giada F; Baldo-Enzi G; Balocchi MR; Zuliani G; Baroni L; Fellin R
    Int J Sports Med; 1988 Aug; 9(4):270-4. PubMed ID: 3141306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of hyperlipidemia in the nephrotic syndrome.
    Attman PO; Alaupovic P
    Am J Nephrol; 1990; 10 Suppl 1():69-75. PubMed ID: 2256478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of gestrinone on serum lipid and lipoprotein levels in women with endometriosis].
    Fukuda Y; Tamura S; Hatanaka S
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):577-84. PubMed ID: 2754288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary excretion of apolipoproteins bound to HDL-like particles in rat nephrotic syndrome and their relation to plasma HDL.
    Shafrir E; Levy E; Deckelbaum R
    Nephron; 1990; 56(1):24-9. PubMed ID: 2234246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of non-HDL fraction to oxidation in experimental nephrotic syndrome.
    Dirican M; Taş S; Sarandöl E; Tokullugil HA
    Kobe J Med Sci; 1998 Dec; 44(5-6):235-45. PubMed ID: 10401226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.